Clinical trial
Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
NCT00414128 · Cambridge University Hospitals NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00414128 |
|---|---|
| Title | Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis |
| Official title | A Randomised Clinical Trial of Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in ANCA Associated Vasculitis. |
| Acronym | MYCYC |
| Lead sponsor | Cambridge University Hospitals NHS Foundation Trust, Other |
| Collaborators | Aspreva Pharmaceuticals Industry Vifor Pharma |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Vasculitis |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil, cyclophosphamide |
| Enrollment | 140 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2011 |
| Completion | Feb 1, 2013 |
| First posted | Dec 21, 2006 |
| Last update posted | Dec 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: